26 jun: Brazil Bank Lending Increases in May, as do Overdue Loans
26 jun: Heinz Names Woodward Head Of North America; O'Hara Leavi..
26-06-2012 16:09:00

Walgreen to Offer Free HIV Testing in 3 Cities Under CDC Pilot Program

Relateret indhold

By Victoria Stilwell

Drugstore giant Walgreen Co. (WAG) will offer free HIV testing in select pharmacies in three markets as a part of a Center for Disease Control and Prevention pilot program designed to increase access to HIV testing, education and care.

The CDC plans to use results from certain pharmacies and in-store clinics in areas identified as highly impacted by HIV to develop a model that pharmacists and nurse practitioners can use to implement nationwide HIV testing.

Certain pharmacies in Chicago and Washington, D.C., and a select clinic in Lithonia, Ga., are offering the free HIV testing, Walgreen said.

If a preliminary positive is revealed, the pharmacy or clinic will refer the patient to a local health care provider for confirmatory testing and care.

"Walgreens is uniquely positioned to advance the role of community pharmacy to become a community health care provider, and this public-private initiative underscores the value of collaboration in helping to raise awareness about HIV testing, prevention and treatment," said Mike Ellis, Walgreen's corporate vice president for specialty and infusion.

Earlier this month Walgreen agreed to buy a 45% stake in the pharmacy-led health and beauty group Alliance Boots GmbH in a $6.7 billion cash and stock deal as it looks to diversify in a changing global health market.

The drugstore chain also reported its fiscal third-quarter earnings fell 11% as sales continued to decline on the loss of Express Scripts Holding Co.'s (ESRX) members. Walgreen at the end of last year allowed a contract with Express Scripts to expire, resulting in some clients going elsewhere to fill their prescriptions.

Shares rose 10 cents to $29.09 in recent trading. The stock is off 12% so far this year.

Write to Victoria Stilwell at Victoria.Stilwell@dowjones.com

(END) Dow Jones Newswires

June 26, 2012 10:09 ET (14:09 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Danske/dir: Har indskærpet reglerne for vores handlere

16-04-2014 15:01:39
I lyset af den bøde, Danske Bank har fået for brud på børsens regler, har banken indskærpet handelsreglerne for sine mange handlere. Det fortæller Henrik Voetma..

Danske Bank får bøde på 410.000 kr. af børsen - NY

16-04-2014 13:11:16
Danske Bank har fået en bøde på 500.000 skr., eller 410.500 kr., af selskabet bag fondsbørsen i København, Nasdaq OMX.Bøden er givet, fordi banken angiveligt ha..

Aktier/middag: Nervøse smil præger fortsat markedet

16-04-2014 11:32:27
Investorerne ser ud til at ville fylde aktiedepoterne op, før kursen sættes mod røget laks, snaps og påskeferie. I hvert fald er de danske aktier i glimrende fo..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
Ingen data fundet.

Relaterede aktiekurser

Walgreen Co 66,75 0,9% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen
Sælg

Relaterede selskaber
Få adgang til information og anbefalinger af relaterede selskaber med PLUS pakken.

Du får adgang til 7 værdifulde investorværktøjer til investering.

Klik her og læs mere om PLUS pakken.
Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
19. april 2014 16:32:35
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20140324.1 - EUROWEB7 - 2014-04-19 16:32:35 - 2014-04-19 16:32:35 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x